Stay updated on Avelumab Program Rollover Study Clinical Trial
Sign up to get notified when there's something new on the Avelumab Program Rollover Study Clinical Trial page.

Latest updates to the Avelumab Program Rollover Study Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedRevision: v3.5.4 was added and Revision: v3.5.3 removed. This indicates a minor update to the page's metadata rather than substantive changes to study content.SummaryDifference0.0%

- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe page shows Revision: v3.5.3, indicating a software/template version update. This update is a backend version bump and does not modify the displayed study details.SummaryDifference0.0%

- Check43 days agoChange DetectedThe page revision label changed from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check50 days agoChange DetectedPadua, Italy has been changed to Padova, Italy in the Locations section.SummaryDifference0.0%

- Check58 days agoChange DetectedKey study timeline fields were updated to reflect revised primary and study completion dates.SummaryDifference0.2%

- Check65 days agoChange DetectedNapoli, Italy was removed and Naples, Italy was added to the list of study locations. The update aligns the location naming with English usage for easier recognition.SummaryDifference0.0%

Stay in the know with updates to Avelumab Program Rollover Study Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avelumab Program Rollover Study Clinical Trial page.